Sagent develops manufacturing deal
SCHAUMBURG - Sagent Pharmaceuticals Inc., a privately held specialty pharmaceutical company, and Itochu Chemical Frontier Corp., a privately held global company in the field of pharmaceutical and organic and fine chemicals based in Japan, announced finalization of a development and supply collaboration. Under the agreement, ICF will supply injectable products for which Sagent will obtain U.S. regulatory approval and market in the United States.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.